Related Experiment Videos
Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors
1Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6140, USA.
The Journal of Pharmacology and Experimental Therapeutics
|November 18, 2000
Summary
Selective 5-HT(2C) receptor agonists reduced immobility in rats, mimicking antidepressant effects. Blocking these receptors diminished the antidepressant-like actions of agonists and fluoxetine, implicating 5-HT(2C) in drug efficacy.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- The 5-HT(2C) receptor is implicated in mood regulation.
- Understanding its role is crucial for developing novel antidepressant therapies.
Purpose of the Study:
- To investigate the role of the 5-HT(2C) receptor in mediating active behaviors in the modified rat forced swim test.
- To assess the effects of selective 5-HT(2C) receptor agonists and antagonists on antidepressant-like behaviors.
Main Methods:
- Utilized a modified rat forced swim test to evaluate behavioral responses.
- Administered novel selective 5-HT(2C) receptor agonists (WAY 161503, RO 60-0175, RO 60-0332), a nonselective agonist (m-chlorophenylpiperazine), a selective antagonist (SB 206533), and fluoxetine.
- Investigated the effects of mianserin, an atypical antidepressant with mixed receptor activity.
Main Results:
- Selective 5-HT(2C) agonists decreased immobility and increased swimming, similar to fluoxetine.
- The nonselective agonist m-chlorophenylpiperazine paradoxically increased immobility.
- The 5-HT(2C) antagonist SB 206533 blocked the antidepressant-like effects of a selective agonist and fluoxetine.
- Mianserin modulated the effects of both the selective agonist and fluoxetine, suggesting complex interactions.
Conclusions:
- The 5-HT(2C) receptor plays a significant role in the behavioral effects of antidepressant drugs.
- The modified rat forced swim test is a valuable tool for distinguishing serotonergic and noradrenergic effects.
- Targeting the 5-HT(2C) receptor may offer a promising strategy for antidepressant drug development.